Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-20-002692
Filing Date
2020-01-09
Accepted
2020-01-09 16:23:54
Documents
1
Effectiveness Date
2020-01-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10378
  Complete submission text file 0001104659-20-002692.txt   11544
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-357587 | Film No.: 20518438
SIC: 2836 Biological Products, (No Diagnostic Substances)